The global obsessive compulsive disorder drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are propelling market growth include increasing R&D investment and a rise in clinical trials by market players, which are expected to fuel the market growth during the forecast period. Obsessive-compulsive disorder (OCD) refers to an anxiety disorder that is characterized by unreasonable and uncontrollable thoughts and fears leading an individual to perform repetitive behaviours. Obsessive-compulsive disorder is a disorder known to compel a person to get stuck on a particular thought or fear. The developments in the treatment, therapies and novel treatment, and advancements in the anti-anxiety, antipsychotic and antidepressant drugs is expected to provide various other opportunities in the OCD drugs market.
The global obsessive compulsive disorder drugs market analysis includes some of the key market players such as Abbott Laboratories, Eli Lilly, and Company, Viatria Inc., H. Lundbeck A/S, Pfizer Inc., among others. In order to maintain a strong position in the market, the market players are adopting various strategic moves, such as product launches, partnerships, collaborations, and mergers and acquisitions. For instance, in August 2021, Alembic Pharmaceuticals declared that it has received final approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Clomipramine Hydrochloride Capsules. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Anafranil Capsules of SpecGX LLC. Clomipramine Hydrochloride Capsules are indicated for the treatment of obsessions and compulsions in patients with obsessive-compulsive disorder (OCD). Alembic has a cumulative total of 149 ANDA approvals from USFDA.
Recent Development:
Market Coverage
Competitive Landscape: Abbott Laboratories, Eli Lilly, and Company, Viatria Inc., H. Lundbeck A/S, Pfizer Inc., among others.
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Obsessive Compulsive Disorder Drugs Market Report Segmentation
By Product
• SSRI
• TCA
• Others
Global Obsessive Compulsive Disorder Drugs Market by Region
North America
Europe
Asia-Pacific
Rest of the World